Pharmacoeconomic implications of new therapies in sepsis

PharmacoEconomics
Kelly A Wood, Derek C Angus

Abstract

Severe sepsis is a major healthcare problem, characterised by a high incidence, mortality and cost. New breakthroughs in treatment are quite diverse, including: (i) more effective regimens for generic, inexpensive broad anti-inflammatory agents (corticosteroids); (ii) a recombinant protein (drotrecogin-alfa [activated]); and (iii) a protocol-based treatment approach (early goal-directed therapy). Economic analyses of new sepsis agents should adopt the societal perspective, which requires prolonging the time horizon beyond that currently typically studied in sepsis trials, so that patient-centred outcomes can be more fully captured. Sepsis affects a very diverse group of patients, and if findings are to be generalisable, careful attention must be paid to study entry criteria and differences in effects and costs across different patient subgroups. Existing care patterns for sepsis are also quite diverse, with the consequence that the incremental effects on costs and outcomes could vary widely by practice pattern, again affecting generalisability. Furthermore, many sepsis patients receive multiple other therapies, which together with therapies under study may have varied and unintended, potentially costly or dangerous adverse effe...Continue Reading

References

Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Jun 23, 1993·JAMA : the Journal of the American Medical Association·L ChelluriA Grenvik
Jan 1, 1996·International Journal of Technology Assessment in Health Care·S HowardA Johnson
Oct 16, 1996·JAMA : the Journal of the American Medical Association·M C WeinsteinL B Russell

❮ Previous
Next ❯

Citations

Nov 20, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Chongxiu SunSarah Y Yuan
Oct 9, 2013·Critical Care : the Official Journal of the Critical Care Forum·Elizabeth D FoxJonathan S Reichner
Oct 15, 2013·Langenbeck's Archives of Surgery·Georg F Weber, Filip K Swirski
Feb 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Krista M KingGregory H Botz
Jun 7, 2014·Colloids and Surfaces. B, Biointerfaces·Matthew P RyderKarl F Schilke
May 9, 2014·Archives of Pathology & Laboratory Medicine·Eric SalazarJames M Musser
Aug 9, 2016·PloS One·Xianfeng WangVidula Vachharajani
Nov 12, 2015·Medizinische Klinik, Intensivmedizin und Notfallmedizin·J C LewejohannT Keck
Apr 18, 2017·Toxicology Mechanisms and Methods·Thivanka MuthumalageChris Pritsos
Mar 16, 2017·Journal of Medical Economics·Jacob CalvertRitankar Das
Sep 27, 2007·Journal of Intensive Care Medicine·Frank R ErnstRebecca L Qualy
Feb 1, 2017·Gerontology & Geriatric Medicine·Brian C PeachJeannie P Cimiotti
Dec 26, 2006·Expert Review of Anticancer Therapy·Martin E GoreAna Montes
Jun 19, 2015·The Journal of Biological Chemistry·Xiaojin ShaXiao-feng Yang
Jan 28, 2017·Clinical Hemorheology and Microcirculation·Anne Krüger-GengeRalf-Peter Franke
Jul 12, 2017·Frontiers in Cellular and Infection Microbiology·Colette G Ngo NdjomHarlan P Jones
Aug 15, 2018·BioMed Research International·György SchneiderTamás Kovács
Dec 13, 2018·Oxidative Medicine and Cellular Longevity·Isabel Matos Medeiros-de-MoraesAdriana Ribeiro Silva
Sep 14, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yin WuGuo-Yun Chen
Jan 7, 2017·BMC Complementary and Alternative Medicine·Hua-Rong LiLei Zhao
Jan 27, 2019·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Brenden K PetersenDaniel M Faissol
May 16, 2018·Frontiers in Immunology·Cassiano Felippe Gonçalves-de-AlbuquerqueHugo Caire de Castro-Faria-Neto
Jun 3, 2020·International Journal of Medical Informatics·Kuo-Ching YuanRay-Jade Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.